Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
Authors:
Open Access
- 1 January 2020
- journal article
- retracted article
- Published by Walter de Gruyter GmbH in Translational Neuroscience
- Vol. 11 (1) , 161-172
Abstract
Background: Amyloid-beta (Aβ) plaque deposits and neurofibrillary tangles containing tau proteins are the key pathognomonic manifestations of Alzheimer’s disease (AD). Lack of holistic drugs for AD has reinvigorated enthusiasm in the natural product-based therapies. In this study, our idea to decipher the beneficial effects of C-phycocyanin (CPC) in the management of AD is buoyed by its multifaceted and holistic therapeutic effects. Methods: We evaluated the effect of CPC treatment on epigenetic factors and inflammatory mediators in a mouse with oligomeric Aβ1-42-induced AD. Besides, the cognitive function was evaluated by the spatial memory performance on a radial arm maze. Results: The results showed cognitive deficit in the mice with AD along with upregulated HDAC3 expression and diminished miRNA-335 and brain-derived neurotrophic factor (BDNF) expressions. In addition, inflammation was provoked (manifested by increased interleukins (IL)-6 and IL-1β) and neuronal apoptosis was accelerated (indicated by increased Bax, caspase-3, and caspase-9 along with decreased Bcl2) in the hippocampus of the mice with AD. Interestingly, CPC treatment in the mice with AD improved spatial memory performance and decreased the perturbations in the epigenetic and inflammatory biofactors. Conclusion: These results underscore that mitigation of inflammation via regulation of epigenetic factors might be the key pathway underlying the ameliorative effect of CPC against the aberrations in AD. Our findings provide the rationale for considering CPC as a viable therapeutic option in the management of AD.Keywords
This publication has 62 references indexed in Scilit:
- Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protectionMolecular Neurodegeneration, 2012
- C-Phycocyanin Attenuates Cisplatin-Induced Nephrotoxicity in MiceRenal Failure, 2012
- Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicityCell Death & Disease, 2012
- Beta-amyloid oligomers: recent developmentsBioMolecular Concepts, 2011
- Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matterActa Neuropathologica, 2010
- Naturally occurring phytochemicals for the prevention of Alzheimer’s diseaseJournal of Neurochemistry, 2010
- Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion proteinProceedings of the National Academy of Sciences, 2010
- The Hippocampus and Spatial Memory: Findings with a Novel Modification of the Water MazeJournal of Neuroscience, 2007
- Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targetsNeurochemistry International, 2002
- Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neuronsJournal of Cell Biology, 2002